Results 221 to 230 of about 270,005 (271)

Cardiopulmonary Bypass in Infants

Journal of Cardiothoracic and Vascular Anesthesia, 2014
THE INCIDENCE of congenital heart defects is approximately 7 to 10 per 1,000 live births. With advancing technology and improved diagnostic, surgical, anesthetic, and postoperative management protocols, the tendency today is to perform the complete repair of defects early in infancy. Infancy is defined as the period from birth until age 1.
Asli, Dönmez, Okan, Yurdakök
openaire   +2 more sources

Normothermic cardiopulmonary bypass

Journal of Cardiothoracic and Vascular Anesthesia, 1997
H YPOTHERMIA and cardiac surgery have been closely linked since Dr F. John Lewis performed the first successful "open heart" surgery under direct vision using vena caval inflow occlusion and generalized hypothermia accomplished by surface cooling in 1952.
A A, Bert, G T, Stearns, W, Feng, A K, Singh   +3 more
openaire   +2 more sources

Cardiopulmonary Bypass in the Cat

Veterinary Surgery, 2002
Objective—To assess the physiologic response to, and acute survival of, cats undergoing cardiopulmonary bypass (CPB) and to evaluate the efficacy of a commercial human pediatric oxygenator system on cats weighing less than 6 kg.Study design—Experimental study.Animals—Six intact male catsMethods—Cats were placed on cardiopulmonary bypass by cannulating ...
Jeff D, Brourman, Eric R, Schertel, David W, Holt, Vincent A, Olshove   +3 more
openaire   +2 more sources

Platelets and cardiopulmonary bypass

Perfusion, 1998
Exposure of blood to an extracorporeal circulation, such as CPB, causes a variety of physiological responses. Haematological derangements are just one of many potential dangers to the patient who undergoes CPB. The paradox of CPB-related problems with the haematological system is that there are some factors tipping the balance towards a bleeding ...
J A, Hyde, J A, Chinn, T R, Graham
openaire   +2 more sources

The coagulopathy of cardiopulmonary bypass

Critical Reviews in Clinical Laboratory Sciences, 2010
There have been numerous publications on the coagulopathy of cardiopulmonary bypass (CPB). This review provides an introduction to the history and main components of current CPB circuits and summarizes the current knowledge of pathogenesis, prevention, and treatment of the CPB coagulopathy.
Martin W, Besser, Andrew A, Klein
openaire   +2 more sources

Thromboelastography and Cardiopulmonary Bypass

Seminars in Thrombosis and Hemostasis, 2012
The TEG tracks postoperative hemorrhage after CPB and is useful in guiding therapy. Its ability to characterize the overall interaction of all procoagulant participants in a final outcome (clot strength) is unique. Much work in the future is needed to establish the particular applications for TEG monitoring in CPB ...
openaire   +2 more sources

Neonatal Cardiopulmonary Bypass

Seminars in Thoracic and Cardiovascular Surgery: Pediatric Cardiac Surgery Annual, 2013
Cardiac surgery with cardiopulmonary bypass is routinely used in neonates who require early repair of congenital heart diseases. However, the bypass temperature and use of deep hypothermic circulatory arrest, the composition of the priming and the acceptable degree of hemodilution, the prophylactic use of antifibrinolytic agents and steroids, the ...
Philippe, Pouard, Mirela, Bojan
openaire   +2 more sources

The platelet in cardiopulmonary bypass

The Annals of Thoracic Surgery, 1998
Platelets are the smallest of the blood cells and are known to be activated during cardiopulmonary bypass. They play a role in many associated complications. Both quantitative and qualitative platelet defects have been demonstrated, resulting in microvascular hemorrhage and thromboembolism.
A, Weerasinghe, K M, Taylor
openaire   +2 more sources

Miniaturization in cardiopulmonary bypass

Perfusion, 2003
Cardiopulmonary bypass (CPB) remains the key technology for more complex cardiac operations. The perfusion equipment used nowadays has seen tremendous progress since its introduction into clinical practice 50 years ago. However, overall, CPB is still far from perfect.
von Segesser LK, Tozzi P, Mallbiabrrena I, Jegger D, Horisberger J, Corno A   +5 more
openaire   +3 more sources

Biomaterials in cardiopulmonary bypass

Perfusion, 1994
The improved utilization of biomaterials in cardiopulmonary bypass is dependent on polymer science and technology, procedures for blood compatibility assessment, optimization of biomaterial/antithrombotic agent combinations and the interpretation of clinical data.
James M. Courtney, Sumuk Sundaram, Bashir M. Matata, John D. S. Gaylor, Charles D. Forbes   +4 more
openaire   +2 more sources